Recent Posts
- Elutia Celebrates First Year; Company Thanks Stakeholders and Employees for a Year of Remarkable Growth and Accomplishment
- Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators
- Elutia to Participate in Upcoming Investor Conferences
- Elutia Announces Second Quarter 2024 Results Launch; Production of EluPro® Underway, Commercial Team Expansion Continues, Financial Position Solidified
- Elutia Announces Full Exercise of Warrants Generating $15.7 Million in Gross Proceeds